• 810 Citations
  • 13 h-Index
20012024
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Radioimmunotherapy Medicine & Life Sciences
Streptavidin Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Fusion reactions Chemical Compounds
Bismuth Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2008 2024

Lymphoma
myc Genes
Neoplasms
Therapeutics
Survival
Hodgkin Disease
Drug Therapy
Therapeutics
Standard of Care
cAC10-vcMMAE
Remission Induction
Multicenter Studies
Maintenance
Therapeutics
ofatumumab
Hematologic Neoplasms
Safety
6-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine

Research Output 2001 2017

  • 810 Citations
  • 13 h-Index
  • 16 Article
  • 4 Review article
  • 2 Letter
  • 1 Chapter
1 Citations

Multivalent interactions between streptavidin-based pretargeting fusion proteins and cell receptors impede efficient internalization of biotinylated nanoparticles

Parker, C. L., Yang, Q., Yang, B., McCallen, J. D., Park, S. I. & Lai, S., Nov 1 2017, In : Acta Biomaterialia. 63, p. 181-189 9 p.

Research output: Contribution to journalArticle

Streptavidin
Cell Fusion
Nanoparticles
Fusion reactions
Proteins
14 Citations

Safety and tolerability of idelalisib, lenalidomide, and rituximab in relapsed and refractory lymphoma: the Alliance for Clinical Trials in Oncology A051201 and A051202 phase 1 trials

Smith, S. M., Pitcher, B. N., Jung, S. H., Bartlett, N. L., Wagner-Johnston, N., Park, S. I., Richards, K. L., Cashen, A. F., Jaslowski, A., Smith, S. E., Cheson, B. D., Hsi, E. & Leonard, J. P., Apr 1 2017, In : The Lancet Haematology. 4, 4, p. e176-e182

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Lymphoma
Clinical Trials
Follicular Lymphoma
Safety
12 Citations

A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma

Park, S. I., Grover, N. S., Olajide, O., Asch, A. S., Wall, J. G., Richards, K. L., Sobol, A. L., Deal, A. M., Ivanova, A., Foster, M. C., Muss, H. B. & Shea, T. C., Oct 1 2016, In : British Journal of Haematology. 175, 2, p. 281-289 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Anthracyclines
Vincristine
Prednisone
Bendamustine Hydrochloride

Differential IgM expression distinguishes two types of pediatric Burkitt lymphoma in mouse and human

Eason, A. B., Sin, S. H., Lin, C., Damania, B., Park, S., Fedoriw, Y., Bacchi, C. E. & Dittmer, D. P., Jan 1 2016, In : Oncotarget. 7, 39, p. 63504-63513 10 p.

Research output: Contribution to journalArticle

Burkitt Lymphoma
Immunoglobulin M
Pediatrics
Brazil
Lymphoma, Large B-Cell, Diffuse

Diffuse large B-cell lymphoma: Diagnosis, treatment and prognosis

Freeman, A. T. & Park, S. I., Jan 1 2016, Diffuse Large B-Cell Lymphoma (DLBCL): Symptoms, Treatment and Prognosis. Nova Science Publishers, Inc., p. 55-74 20 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Lymphoma, Large B-Cell, Diffuse
Non-Hodgkin's Lymphoma
Therapeutics
Drug Therapy
Standard of Care